Combined Expression of CD34 and FLT3-Internal Tandem Duplication Mutation Predicts Poor Response to Treatment in Acute Myeloid Leukemia.

Mona S Abdellateif Amira Bisher Kassem Yomna M El-Meligui

Published in: International journal of general medicine (2020)

Combined expression of both FLT3-ITD mutation and CD34 expression is an important prognostic and predictive factor for poor disease outcome in AML patients.

Keyphrases

acute myeloid leukemia
poor prognosis
end stage renal disease
binding protein
chronic kidney disease
ejection fraction
newly diagnosed
tyrosine kinase
long non coding rna
allogeneic hematopoietic stem cell transplantation
acute lymphoblastic leukemia
combination therapy